Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/02/2011
PIL Fragmin - Haemodialysis/Haemofiltration (1ml and 4ml Ampoules)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/12/2010 and displayed until 14/02/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 16/07/2010 and displayed until 08/12/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 15/09/2009 and displayed until 16/07/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/07/2009 and displayed until 15/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 25/11/2008 and displayed until 15/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 14/04/2008 and displayed until 25/11/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/02/2008 and displayed until 14/04/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/01/2008 and displayed until 07/02/2008
Reasons for adding or updating:
  • Change from BAN to rINN
  • Change to date of revision
Updated on 13/09/2007 and displayed until 10/01/2008
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
Updated on 08/04/2004 and displayed until 13/09/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  dalteparin sodium